NCCN Guidelines for Patients® | Pancreatic Cancer - page 62

60
NCCN Guidelines for Patients
®
Pancreatic Cancer, Version 1.2014
5.3
Treatment guide
Borderline resectable pancreatic cancer
Tests
Test results
Treatment
Possible
biopsy
Local
recurrence
Metastatic
cancer
Chart 5.3.5 Treatment for recurrence after surgery
Clinical trial (preferred),
Different chemotherapy than before, or
Palliative and best supportive care
Clinical trial (preferred),
Chemoradiation if not given before,
Different chemotherapy than before, or
Palliative and best supportive care
Clinical trial (preferred),
Same chemotherapy given before,
Different chemotherapy than before, or
Palliative and best supportive care
>6 months
since last
treatment
<6 months
since last
treatment
Chart 5.3.5
shows the tests and treatments that are
recommended when there is a return (recurrence) of
cancer after surgery and adjuvant treatment.
Tests and results
First, you may have a biopsy to confirm pancreatic
cancer if not done previously. A biopsy is the removal
of a sample of tissue from your body to test for cancer
cells. Once pancreatic cancer is confirmed, you can
receive treatment. Based on these tests, your doctors
will know how far the cancer has spread. Cancer that
came back in or near the pancreas is called a local
recurrence. Cancer that has spread to sites far away
from the pancreas is called metastatic cancer.
Treatment
For pancreatic cancer recurrence, joining a clinical
trial is always the preferred treatment choice above
any other option. A clinical trial is a type of research
that studies the safety and effectiveness of a test or
treatment. (See page 30 for more details on clinical
trials.) Best supportive care without active cancer
treatment should also be considered, especially
for patients with a poor health status. Your health
1...,52,53,54,55,56,57,58,59,60,61 63,64,65,66,67,68,69,70,71,72,...92
Powered by FlippingBook